Zymeworks Inc.
Bispecific Asymmetric Heterodimers Comprising Anti-CD3 Constructs

Last updated:

Abstract:

Disclosed herein are isolated multi-specific heteromultimer constructs that bind to CD3 expressed on T-cells and to an antigen expressed on B-cells. The multi-specific heteromultimer constructs are capable of bridging T- and B-cells and mediating killing of B-cells. The multi-specific heteromultimer constructs are based on a heterodimeric Fc scaffold or on a segmented albumin scaffold. Also disclosed herein are multi-specific heteromultimer constructs that bind to HER2 and HER3.

Status:
Application
Type:

Utility

Filling date:

24 Jan 2019

Issue date:

15 Aug 2019